 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
DURECT TO PRESENT AT PIPER JAFFRAY HEALTHCARE CONFERENCE
Cupertino, CA-
November 20, 2007
CUPERTINO, CA, November 20, 2007/ PRNewswire-First Call via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present a corporate overview and update at the 19th Annual Piper Jaffray Health Care Conference on Tuesday, November 27, 2007 at 4:00 p.m. EST at The Pierre Hotel in New York.
A live audio webcast of the presentation will be available by accessing DURECT’s homepage at http://www.durect.com and clicking “Investor Relations”. If you are unable to participate during the live webcast, the call will be archived on DURECT’s website under Audio Archive in the “Investor Relations” section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit www.durect.com.
SOURCE: DURECT Corporation
CONTACT: Matthew J. Hogan, Chief Financial Officer, +1-408-777-4936
|
|
|
| © 2000-2010 DURECT Corporation |
| Last updated: March 11, 2010 |
|
|
|
